Hip Arthropathy, Knee Arthropathy, Prosthetic-joint Infection, Surgery
Conditions
Keywords
Joint prostheses, Joint surgery, Knee, Hip
Brief summary
The aim of the study is to examine patients after knee and hip endoprosthesis in the longitudinal section and to evaluate the surgical outcome.
Detailed description
In 2022, around 255,000 total hip arthroplasties and around 200,000 total knee arthroplasties were implanted in Germany and treated on an inpatient basis. However, studies show that 15-30% of patients are not satisfied with the postoperative outcome of total knee arthroplasty. Various factors, such as preoperative pain and mental and physical health, are important for subjective satisfaction. For the objective functional results, other factors such as the indication, age and lifestyle are added, which can influence the postoperative result. These figures initially relate to primary joint replacement. However, it is not uncommon for a repeat procedure, known as a revision, to be indicated postoperatively. In Germany, for example, 12.6% of knee endoprostheses required revision in 2018. Studies have shown that the most common reasons for hip revision are aseptic loosening in 23% of cases, functional instability in 22% and periprosthetic infection (PPI) in 22%. With an incidence of 1-2% and increasing case numbers, PPI is a relevant problem in arthroplasty treatment. In the postoperative course, a bacterial infection of the prosthesis-bearing bone, the joint and/or the surrounding tissue occurs. If symptoms persist or the prosthesis is unstable, a one-stage or two-stage prosthesis replacement with subsequent antibiotic therapy is performed. When choosing the treatment, the focus should be on improving quality of life, which includes reducing pain, maintaining function and, last but not least, reducing infection-related morbidity and mortality. In order to be able to comprehensively track the course of treatment of joint surgery patients (preoperative condition, surgery performed, subsequent hospitalization, postoperative outcome, any subsequent complications and further interventions), structural and temporally consistent documentation and examinations of patients are required. The aim of the study is to correlate the multiple parameters that influence the course of treatment and the surgical outcome and thus obtain a holistic picture of the patient in order to improve joint surgery care. Primary questions: 1. How does the physical and mental health status of patients change after joint surgery? 2. How does the body composition change after joint revision? 3. How does the perceived pain change perioperatively? Secondary questions: 1. What is the impact of joint surgery and hospitalised stay on functional characteristics such as muscular status of patients? 2. What influence does the chosen procedure (one-stage vs. two-stage/long vs. short interval) in revision arthroplasty have on the course of treatment? 3. How does the global and local bone density adapt after the use of metaphyseal components in knee joint replacement? 4. Utilisation of osteoarthritic cartilage cells for testing novel therapeutic methods to stimulate cartilage regenerative processes. 5. Do osteoarthritic cartilage cells from different donors differ in their functional phenotype? 6. What role does the immune system play in the pre-, peri- and postoperative course of joint surgery? 7. How can joint infection be better diagnosed and treated?
Interventions
PROCEDUREJoint replacement
Patients routinely receive a joint replacement.
Sponsors
University Hospital, Bonn
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Inclusion criteria
* There is an indication for primary knee or hip replacement or revision. * The subject is over 18 years of age. * Written consent is given if the subject is fully responsible.
Exclusion criteria
* A known pregnancy * A known mental or pain-associated illness * Illness of an airborne infectious disease with an increased risk of mortality and morbidity * Patient intolerances or restrictions that make participation in the study impossible
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| SF 12 Questionnaire | preoperative (approx. 1Day), postoperative (approx. 7 Days), 6-8 weeks postoperative | Health-related quality of life assessed by the SF-12 (score for physical components (PCS) and total score for mental components (MCS) - higher values mean better health, lower values mean worse health with a statistical mean of the total score of 50 (SD 10) (1-100) |
| Hand-held dynamometer | preoperative (approx. 1Day), postoperative (approx. 7 Days), 6-8 weeks postoperative | Hand grip force using a hand dynamometer in absolute values (in kg). |
| Dual-Energy X-Ray Absorptiometry | preoperative (approx. 1Day) | Bone density values by DXA measurement (T- or Z-values as deviation of the measured value from predefined mean values. T-Score ≤ -1 = osteopenia; T-Score ≤ -2,5 = osteoporosis. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Joint examination (HJHS) | preoperative (approx. 1Day) | The hemophilia joint health score is a combined test of questioning and clinical examination with a goniometer and examines both elbow, knee and ankle joints using a goniometer for range of motion and axial alignment (0-3 points), pain numerical rating scale (0-10 points), swelling (0-3 points), crepitation (0-2 points) and gait abnormalities (0-4 points). A "total score" of 0 to 124 points is achievable. A higher score means a worse joint status. |
| Hip examination (Harris Hip Score) | preoperative (approx. 1Day), postoperative (approx. 7 Days), 6-8 weeks postoperative | The Harris Hip Score is is a combined test of questioning and clinical examination with a goniometer to assess hip complaints. The perceived pain, the function of the joint, existing deformities and the range of motion are assessed or queried with a total score of 0-100 points, with a low score indicating a functionally poorer hip joint. |
| Knee examination (Knee Society Score) | preoperative (approx. 1Day), postoperative (approx. 7 Days), 6-8 weeks postoperative | The Knee Society Score is a combined test of questioning and clinical examination with a goniometer and evaluates the functional ability of the knee joint after total or partial knee arthroplasty. This includes objective (knee alignment, knee instability, range of motion), functional (standard and advanced activities) and subjective (patient expectations and satisfaction, symptoms) components. A total of 0-100 points can be achieved, with a lower value signaling a poorer assessment of the knee joint. |
| Blood samples | preoperative (approx. 1Day), postoperative (approx. 7 Days), 6-8 weeks postoperative | The blood samples of all patients are collected in the clinical routine in preparation for surgery and during the inpatient stay. As part of the study, the parameters vitamin D3 (nmol/l), calcium (nmol/l), creatine kinase (U/l), TSH (µu/ml), C-reactive protein (mg/l), leukocytes (G/l), hemoglobin (%) are used for statistical analyses. |
| Biomaterial | during operation | Biomaterial that is obtained/discarded as standard during the surgical procedure (Bone, cartilage, synovial fluid, synovial mucosa, Hoffa fat bodies). After preparation, the samples are stored at -80°C or -150°C until the measurements. Once the sample collection is complete, the stored samples are further processed for the measurements according to the manufacturer's instructions in order to determine and quantify inflammatory mediators or cell populations from the blood and tissue samples using an immunoassay (e.g. ELISA, multiplex approach, flow cytometry, proteomics, RNAseq, in vitro functional assay). The inflammatory mediators/cell populations are then analysed pseudonymously on the basis of the clinical course and in the context of the microbiological, histological, laboratory chemical and imaging findings from the patient file, which were routinely collected during the inpatient stay. |
Countries
Germany
Contacts
CONTACTAndreas C. Strauss, PD Dr. med.
PRINCIPAL_INVESTIGATORAndreas C. Strauss, PD Dr. med.
University Hospital, Bonn
Outcome results
None listed